Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

ToleroGenics Inc
Profile last edited on: 4/9/14      CAGE: 4ZHM1      UEI:

Business Identifier: antibodies for treating autoimmune diseases
Year Founded
2008
First Award
2011
Latest Award
2011
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

20 North Wacker Drive Suite 1201
Chicago, IL 60606
   (312) 251-0700
   annalisasomera@yahoo.com
   N/A
Location: Single
Congr. District: 07
County: Cook

Public Profile

oleroGenics, Inc. manufactures antibodies for treating autoimmune diseases. The company offers a bi-specific antibody for treating Type I diabetes.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$192,679
Phase II Dollars
$0
Total Awarded
$192,679

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2011 1 NIH $192,679
Project Title: Use of Bispecific Antibody for Treating Non-Obese Diabetes

Key People / Management

  Bellur S Prabhakar

Company News

There are no news available.